Protect your future with geneType risk assessment|Simon Morriss,CEO,Genetic Technologies Ltd 00:10:00

Share On Facebook Share On Twitter

Mr. Morriss was appointed as Chief Executive Officer on 1 February 2021 and brings over 20 years of experience within the Pharmaceutical, Healthcare and FMCG industries having held senior executive positions at Sanofi and Blackmores. He brings a wealth of experience in managing teams and successfully executing across sales, marketing and brand building.

Recent Videos